325 related articles for article (PubMed ID: 17804751)
41. Selection and analysis of anti-cancer antibodies for cancer therapy obtained from antibody phage library.
Kurosawa G; Sumitomo M; Ukai Y; Subere J; Muramatsu C; Eguchi K; Tanaka-Hashiba M; Sugiura M; Ando M; Sato N; Morita M; Inaba K; Morigaki S; Takasaki A; Akahori Y; Miyakawa S; Uyama I; Maeda K; Shiroki R; Hoshinaga K; Mizoguchi Y; Hattori Y; Sugioka A; Sugiura M; Kurosawa Y
Cancer Sci; 2011 Jan; 102(1):175-81. PubMed ID: 21040215
[TBL] [Abstract][Full Text] [Related]
42. Identification of HCC-22-5 tumor-associated antigen and antibody response in patients.
Zhou SF; Xie XX; Bin YH; Lan L; Chen F; Luo GR
Clin Chim Acta; 2006 Apr; 366(1-2):274-80. PubMed ID: 16356486
[TBL] [Abstract][Full Text] [Related]
43. [Study on binding characteristics of 125I-labeled McAb LC-1 to lung adenocarcinoma cells in vitro and in vivo].
Li M; Lian BJ; Ge XR
Shi Yan Sheng Wu Xue Bao; 1992 Mar; 25(1):31-8. PubMed ID: 1598801
[TBL] [Abstract][Full Text] [Related]
44. [An experimental study on targeting suicide gene therapy for lung cancer with HSV-TK driven by hTERT promoter].
Wang YP; Tang XJ; Zhou QH; Che GW; Chen XH; Zhu DX
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):701-5. PubMed ID: 19024294
[TBL] [Abstract][Full Text] [Related]
45. [Monoclonal antibody against brain derived neurotrophic factor inhibits myeloma growth and angiogenesis in the xenograft NOD/SCID animal model].
Wang YD; Hu Y; Zhang L; Huang J; Sun CY
Zhonghua Xue Ye Xue Za Zhi; 2007 Oct; 28(10):659-63. PubMed ID: 18399169
[TBL] [Abstract][Full Text] [Related]
46. A streptococcal preparation (OK-432) enhances monoclonal antibody NCC-ST-421 cytotoxicity against human colon cancer.
Kawano Y; Watanabe M; Kubota T; Nishibori H; Kurihara N; Teramoto T; Kitajima M
Anticancer Res; 1997; 17(4A):2449-53. PubMed ID: 9252661
[TBL] [Abstract][Full Text] [Related]
47. Apoptosis induction of human lung cancer cell line in multicellular heterospheroids with humanized antiganglioside GM2 monoclonal antibody.
Nakamura K; Hanibuchi M; Yano S; Tanaka Y; Fujino I; Inoue M; Takezawa T; Shitara K; Sone S; Hanai N
Cancer Res; 1999 Oct; 59(20):5323-30. PubMed ID: 10537316
[TBL] [Abstract][Full Text] [Related]
48. Immunohistochemical characterization of tumor liberated particles (TLP) expression pattern in lung cancer.
Tarro G; Esposito C; Perna A; Claudio PP; Giordano A
Anticancer Res; 1998; 18(4A):2365-70. PubMed ID: 9703880
[TBL] [Abstract][Full Text] [Related]
49. [McAb LC-1 against human lung cancer].
Ge XR; Wang J; Lin SJ; Yu NX; Che YF; Gu Y
Shi Yan Sheng Wu Xue Bao; 1989 Sep; 22(3):359-65. PubMed ID: 2555985
[TBL] [Abstract][Full Text] [Related]
50. Humanized anti-CD26 monoclonal antibody as a treatment for malignant mesothelioma tumors.
Inamoto T; Yamada T; Ohnuma K; Kina S; Takahashi N; Yamochi T; Inamoto S; Katsuoka Y; Hosono O; Tanaka H; Dang NH; Morimoto C
Clin Cancer Res; 2007 Jul; 13(14):4191-200. PubMed ID: 17634548
[TBL] [Abstract][Full Text] [Related]
51. Immunotherapy for recurrent colorectal cancers with human monoclonal antibody SK-1.
Koda K; Glassy MC; McKnight ME; Yasutomi J; Saito N; Dan M; Nakajima N
Anticancer Res; 2001; 21(1B):621-7. PubMed ID: 11299816
[TBL] [Abstract][Full Text] [Related]
52. Tumor associated antigen recognition by autologous serum in patients with breast cancer.
Qian F; Odunsi K; Blatt LM; Scanlan MJ; Mannan M; Shah N; Montgomery J; Haddad F; Taylor M
Int J Mol Med; 2005 Jan; 15(1):137-44. PubMed ID: 15583840
[TBL] [Abstract][Full Text] [Related]
53. p53 Cooperates berberine-induced growth inhibition and apoptosis of non-small cell human lung cancer cells in vitro and tumor xenograft growth in vivo.
Katiyar SK; Meeran SM; Katiyar N; Akhtar S
Mol Carcinog; 2009 Jan; 48(1):24-37. PubMed ID: 18459128
[TBL] [Abstract][Full Text] [Related]
54. Tranilast inhibits hormone refractory prostate cancer cell proliferation and suppresses transforming growth factor beta1-associated osteoblastic changes.
Izumi K; Mizokami A; Li YQ; Narimoto K; Sugimoto K; Kadono Y; Kitagawa Y; Konaka H; Koh E; Keller ET; Namiki M
Prostate; 2009 Aug; 69(11):1222-34. PubMed ID: 19434660
[TBL] [Abstract][Full Text] [Related]
55. Activated T-cell-mediated immunotherapy with a chimeric receptor against CD38 in B-cell non-Hodgkin lymphoma.
Mihara K; Yanagihara K; Takigahira M; Imai C; Kitanaka A; Takihara Y; Kimura A
J Immunother; 2009 Sep; 32(7):737-43. PubMed ID: 19561535
[TBL] [Abstract][Full Text] [Related]
56. Identification of a 220-kDa membrane tumor-associated antigen by human anti-UK114 monoclonal antibodies selected from the immunoglobulin repertoire of a cancer patient.
Funaro A; Horenstein AL; Ghisolfi G; Bussolati B; Bartorelli A; Bussolati G
Exp Cell Res; 1999 Mar; 247(2):441-50. PubMed ID: 10066372
[TBL] [Abstract][Full Text] [Related]
57. The novel chimeric anti-NCAM (neural cell adhesion molecule) antibody ch.MK1 displays antitumor activity in SCID mice but does not activate complement-dependent cytolysis (CDC).
Klehr M; Koehl U; Mühlenhoff M; Tawadros S; Fischer T; Schomäcker K; Heuckmann JM; Bochennek K; Jensen M
J Immunother; 2009 Jun; 32(5):442-51. PubMed ID: 19609236
[TBL] [Abstract][Full Text] [Related]
58. Advances in specific immunotherapy for prostate cancer.
Kiessling A; Füssel S; Wehner R; Bachmann M; Wirth MP; Rieber EP; Schmitz M
Eur Urol; 2008 Apr; 53(4):694-708. PubMed ID: 18061335
[TBL] [Abstract][Full Text] [Related]
59. Reevaluation of the 22-1-1 antibody and its putative antigen, EBAG9/RCAS1, as a tumor marker.
Reimer TA; Anagnostopoulos I; Erdmann B; Lehmann I; Stein H; Daniel P; Dörken B; Rehm A
BMC Cancer; 2005 May; 5():47. PubMed ID: 15904507
[TBL] [Abstract][Full Text] [Related]
60. Human lung tumor growth established in the lung and subcutaneous tissue of mice with severe combined immunodeficiency.
Reddy S; Piccione D; Takita H; Bankert RB
Cancer Res; 1987 May; 47(9):2456-60. PubMed ID: 3567931
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
